Veterinary Vaccine Adjuvants Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Veterinary Vaccine Adjuvants Market
The veterinary vaccine adjuvants market size was valued at USD 380.0 million in 2019, and the market is now projected to USD 661.0 million by 2032, exhibiting a CAGR of 4.4% during the forecast period of 2020-2032.
The increased implementation of companion animals has augmented the demand for these vaccinations and it has supported the market expansion. Numerous people came to know about the adaptability and response of the veterinarian medical sector to a potential infectious disease. They are used for maintaining mammal health and protecting human public wellbeing has increased the need for the product. Hence, the COVID-19 pandemic has reinforced the veterinary vaccine adjuvants market growth.
The veterinary vaccine adjuvants market share globally has increased due to the increasing knowledge of animal health in the developing regions. The governments from emerging countries have started various promotional campaigns to support the advantages of animal husbandry. In addition, there are a number of initiatives taken by organizations to spread awareness concerning the health of animals and to manage the widening of zoonotic infections. For handling the infectious diseases there is growing demand for such kind antidotes. These are the aspects which are boosting the market growth.
The trend is development of novel adjuvant technological advancements for animal vaccines is fostering market growth. Veterinary antidotes have been used for many years that offer an important function in protecting animal welfare, animal health, food production, and public health. These products are cost-effective and are utilized to prevent animal disease and recover food production. In addition, vaccines significantly reduce the need for antibiotics to take care of cohort animals and avoid transmission of zoonotic disease to humans. Alum and emulsions-based formulations are productively used for a longer time in a wide diversity of animal vaccinations. A wide range of adjuvants has been successfully utilized in commercial antiseptics for animals and several new technologies are at present in preclinical development are fueling the market growth.
Comprehensive Analysis of Veterinary Vaccine Adjuvants Market
This market expansion effectively provides a detailed regional evaluation considering the dominant supply and demand forces that impact the healthcare industry. The veterinary vaccine adjuvants market and healthcare industry is growing at an exponential rate caused by its market segmentation. These segmentations are methodically segregated by type, application, route of admin-istration, and animal type. The types are alum and calcium salts, liposomes, oil emulsion adjuvants, and archaeosomes, nanoparticles and Mi-croparticles, and others. The applications are research, and commercial. The routes of admin-istrations involve oral, subcutaneous, intramuscular, and others. The animal types comprise livestock and companion animals.
The North American region is conducive to the global veterinary vaccine adjuvants market, leading to a recall of USD 158.8 million owing to the existence of well-established veterinary healthcare infrastructure supporting the market growth in the region.
The top players in the market play a vital role in the healthcare industry assuring industrial prospectus growth and setting market values. These players include Merck & Co., Inc. (U.S), Croda International Plc (UK), Zoetis (U.S.), Phibro Animal Health Corporation (U.S), SEPPIC (France), SPI Pharma (U.S.), Bioveta, a.s. (Czechia), OZ Biosciences (France), Avanti Polar Lipids, Inc. (U.S), InvivoGen (U.S), and Others, these market players provide a level-playing competitive landscape.
In July 2021, Merck Animal Health expanded its SEQUIVITY veterinary prescription vaccine platform. It is a novel antidote for rising enteric disease and it included sapovirus, a virus causing diarrhea in young pigs.
Segmentation Table
Global Veterinary Vaccine Adjuvants Market Scope
ATTRIBUTE DETAILS
Study Period 2016-2027
Base Year 2019
Forecast Period 2020-2027
Historical Period 2016-2018
UnitValue (USD million)
By Type
Alum and Calcium Salts
Oil Emulsion Adjuvants
Liposomes and Archaeosomes
Nanoparticles and Microparticles
Others
SEGMENTATIONBy Application
Research Application
Commercial Application
By Route of Administration
Oral
Subcutaneous
Intramuscular
Others
By Animal Type
Livestock
Companion Animals
By Geography
North America (the U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, and the Rest of Europe)
Asia Pacific (India, Japan, Australia, Southeast Asia, China, and the Rest of Asia Pacific)
Latin America (Brazil, Mexico, Rest of Latin America)
The Middle East and Africa (GCC, South Africa, Rest of MEA)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Market Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Snapshot: Veterinary Vaccines Adjuvants Technology
- 4.2. Overview of New Vaccines Delivery Modes
- 4.3. Advancements in Animal Health Vaccines
- 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
- 5. Global Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Alum and Calcium Salts
- 5.2.2. Oil Emulsion Adjuvants
- 5.2.3. Liposomes and Archaeosomes
- 5.2.4. Nanoparticles and Microparticles
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Research
- 5.3.2. Commercial
- 5.4. Market Analysis, Insights and Forecast – By Route of Administration
- 5.4.1. Oral
- 5.4.2. Subcutaneous
- 5.4.3. Intramuscular
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Animal Type
- 5.5.1. Livestock Animals
- 5.5.2. Companion Animals
- 5.6. Market Analysis, Insights and Forecast – By Geography
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
- 6. North America Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Alum and Calcium Salts
- 6.2.2. Oil Emulsion Adjuvants
- 6.2.3. Liposomes and Archaeosomes
- 6.2.4. Nanoparticles and Microparticles
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Research
- 6.3.2. Commercial
- 6.4. Market Analysis, Insights and Forecast – By Route of Administration
- 6.4.1. Oral
- 6.4.2. Subcutaneous
- 6.4.3. Intramuscular
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Animal Type
- 6.5.1. Livestock Animals
- 6.5.2. Companion Animals
- 6.6. Market Analysis, Insights and Forecast – By Country
- 6.6.1. U.S.
- 6.6.2. Canada
- 7. Europe Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Alum and Calcium Salts
- 7.2.2. Oil Emulsion Adjuvants
- 7.2.3. Liposomes and Archaeosomes
- 7.2.4. Nanoparticles and Microparticles
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Research
- 7.3.2. Commercial
- 7.4. Market Analysis, Insights and Forecast – By Route of Administration
- 7.4.1. Oral
- 7.4.2. Subcutaneous
- 7.4.3. Intramuscular
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast – By Animal Type
- 7.5.1. Livestock Animals
- 7.5.2. Companion Animals
- 7.6. Market Analysis, Insights and Forecast – By Country/Sub-region
- 7.6.1. U.K.
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Spain
- 7.6.5. Italy
- 7.6.6. Scandinavia
- 7.6.7. Rest of Europe
- 8. Asia Pacific Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Alum and Calcium Salts
- 8.2.2. Oil Emulsion Adjuvants
- 8.2.3. Liposomes and Archaeosomes
- 8.2.4. Nanoparticles and Microparticles
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Research
- 8.3.2. Commercial
- 8.4. Market Analysis, Insights and Forecast – By Route of Administration
- 8.4.1. Oral
- 8.4.2. Subcutaneous
- 8.4.3. Intramuscular
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Animal Type
- 8.5.1. Livestock Animals
- 8.5.2. Companion Animals
- 8.6. Market Analysis, Insights and Forecast – By Country/Sub-region
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. Australia
- 8.6.5. Southeast Asia
- 8.6.6. Rest of Asia Pacific
- 9. Latin America Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Alum and Calcium Salts
- 9.2.2. Oil Emulsion Adjuvants
- 9.2.3. Liposomes and Archaeosomes
- 9.2.4. Nanoparticles and Microparticles
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Research
- 9.3.2. Commercial
- 9.4. Market Analysis, Insights and Forecast – By Route of Administration
- 9.4.1. Oral
- 9.4.2. Subcutaneous
- 9.4.3. Intramuscular
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Animal Type
- 9.5.1. Livestock Animals
- 9.5.2. Companion Animals
- 9.6. Market Analysis, Insights and Forecast – By Country/Sub-region
- 9.6.1. Brazil
- 9.6.2. Mexico
- 9.6.3. Rest of Latin America
- 10. Middle East & Africa Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Type
- 10.2.1. Alum and Calcium Salts
- 10.2.2. Oil Emulsion Adjuvants
- 10.2.3. Liposomes and Archaeosomes
- 10.2.4. Nanoparticles and Microparticles
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast – By Application
- 10.3.1. Research
- 10.3.2. Commercial
- 10.4. Market Analysis, Insights and Forecast – By Route of Administration
- 10.4.1. Oral
- 10.4.2. Subcutaneous
- 10.4.3. Intramuscular
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast – By Animal Type
- 10.5.1. Livestock Animals
- 10.5.2. Companion Animals
- 10.6. Market Analysis, Insights and Forecast – By Country/Sub-region
- 10.6.1. GCC
- 10.6.2. South Africa
- 10.6.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2019)
- 11.3. Company Profiles (Overview, Type Types & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
- 11.3.1. Croda International Plc (UK)
- 11.3.1.1. Overview,
- 11.3.1.2. Type Types & Services,
- 11.3.1.3. SWOT Analysis,
- 11.3.1.4. Recent Developments,
- 11.3.1.5. Strategies,
- 11.3.1.6. Financials (Based on Availability)
- 11.3.2. Zoetis (U.S.)
- 11.3.2.1. Overview,
- 11.3.2.2. Type Types & Services,
- 11.3.2.3. SWOT Analysis,
- 11.3.2.4. Recent Developments,
- 11.3.2.5. Strategies,
- 11.3.2.6. Financials (Based on Availability)
- 11.3.3. Phibro Animal Health Corporation (U.S)
- 11.3.3.1. Overview,
- 11.3.3.2. Type Types & Services,
- 11.3.3.3. SWOT Analysis,
- 11.3.3.4. Recent Developments,
- 11.3.3.5. Strategies,
- 11.3.3.6. Financials (Based on Availability)
- 11.3.4. SEPPIC (France)
- 11.3.4.1. Overview,
- 11.3.4.2. Type Types & Services,
- 11.3.4.3. SWOT Analysis,
- 11.3.4.4. Recent Developments,
- 11.3.4.5. Strategies,
- 11.3.4.6. Financials (Based on Availability)
- 11.3.5. SPI Pharma (U.S)
- 11.3.5.1. Overview,
- 11.3.5.2. Type Types & Services,
- 11.3.5.3. SWOT Analysis,
- 11.3.5.4. Recent Developments,
- 11.3.5.5. Strategies,
- 11.3.5.6. Financials (Based on Availability)
- 11.3.6. Bioveta, a.s. (Czechia)
- 11.3.6.1. Overview,
- 11.3.6.2. Type Types & Services,
- 11.3.6.3. SWOT Analysis,
- 11.3.6.4. Recent Developments,
- 11.3.6.5. Strategies,
- 11.3.6.6. Financials (Based on Availability)
- 11.3.7. Merck & Co., Inc. (U.S)
- 11.3.7.1. Overview,
- 11.3.7.2. Type Types & Services,
- 11.3.7.3. SWOT Analysis,
- 11.3.7.4. Recent Developments,
- 11.3.7.5. Strategies,
- 11.3.7.6. Financials (Based on Availability)
- 11.3.8. Avanti Polar Lipids, Inc. (U.S)
- 11.3.8.1. Overview,
- 11.3.8.2. Type Types & Services,
- 11.3.8.3. SWOT Analysis,
- 11.3.8.4. Recent Developments,
- 11.3.8.5. Strategies,
- 11.3.8.6. Financials (Based on Availability)
- 11.3.9. OZ Biosciences FRANCE
- 11.3.9.1. Overview,
- 11.3.9.2. Type Types & Services,
- 11.3.9.3. SWOT Analysis,
- 11.3.9.4. Recent Developments,
- 11.3.9.5. Strategies,
- 11.3.9.6. Financials (Based on Availability)
- 11.3.10. InvivoGen (U.S)
- 11.3.10.1. Overview,
- 11.3.10.2. Type Types & Services,
- 11.3.10.3. SWOT Analysis,
- 11.3.10.4. Recent Developments,
- 11.3.10.5. Strategies,
- 11.3.10.6. Financials (Based on Availability)
- 11.3.11. Other Prominent Players
- 11.3.11.1. Overview,
- 11.3.11.2. Type Types & Services,
- 11.3.11.3. SWOT Analysis,
- 11.3.11.4. Recent Developments,
- 11.3.11.5. Strategies,
- 11.3.11.6. Financials (Based on Availability)
- 12. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook